Concepts (254)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant, Premature | 35 | 2025 | 199 | 5.490 |
Why?
|
| Bronchopulmonary Dysplasia | 20 | 2025 | 32 | 5.150 |
Why?
|
| Infant, Premature, Diseases | 10 | 2021 | 49 | 2.840 |
Why?
|
| Infant, Newborn | 47 | 2025 | 1437 | 2.400 |
Why?
|
| Oxygen Inhalation Therapy | 7 | 2025 | 61 | 2.330 |
Why?
|
| Apnea | 6 | 2017 | 33 | 1.760 |
Why?
|
| Oximetry | 8 | 2025 | 53 | 1.680 |
Why?
|
| Infant | 29 | 2025 | 1710 | 1.420 |
Why?
|
| Gestational Age | 13 | 2025 | 194 | 1.360 |
Why?
|
| Child Restraint Systems | 4 | 2017 | 6 | 1.310 |
Why?
|
| Oxygen | 6 | 2022 | 321 | 1.120 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2017 | 61 | 0.970 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 2 | 2024 | 4 | 0.880 |
Why?
|
| Length of Stay | 3 | 2017 | 828 | 0.860 |
Why?
|
| Carbon Dioxide | 2 | 2024 | 81 | 0.850 |
Why?
|
| Caffeine | 4 | 2017 | 46 | 0.780 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2022 | 13 | 0.730 |
Why?
|
| Bradycardia | 4 | 2017 | 33 | 0.720 |
Why?
|
| Ventilator Weaning | 2 | 2011 | 21 | 0.700 |
Why?
|
| Home Care Services, Hospital-Based | 2 | 2020 | 5 | 0.690 |
Why?
|
| Central Nervous System Stimulants | 3 | 2017 | 66 | 0.640 |
Why?
|
| Intensive Care Units, Neonatal | 7 | 2025 | 104 | 0.640 |
Why?
|
| Feeding Methods | 1 | 2019 | 11 | 0.600 |
Why?
|
| Ambulatory Care | 2 | 2024 | 318 | 0.590 |
Why?
|
| Hypoxia | 3 | 2017 | 121 | 0.580 |
Why?
|
| Enteral Nutrition | 1 | 2019 | 53 | 0.580 |
Why?
|
| Humans | 55 | 2025 | 65632 | 0.580 |
Why?
|
| Monitoring, Physiologic | 3 | 2024 | 169 | 0.570 |
Why?
|
| Catheterization, Central Venous | 1 | 2019 | 84 | 0.560 |
Why?
|
| Birth Weight | 2 | 2022 | 83 | 0.550 |
Why?
|
| Premature Birth | 4 | 2023 | 116 | 0.550 |
Why?
|
| Neuromuscular Diseases | 2 | 2017 | 24 | 0.540 |
Why?
|
| Craniofacial Abnormalities | 1 | 2017 | 23 | 0.520 |
Why?
|
| Retrospective Studies | 17 | 2025 | 6946 | 0.510 |
Why?
|
| Body Weight | 3 | 2020 | 377 | 0.510 |
Why?
|
| Term Birth | 1 | 2016 | 6 | 0.500 |
Why?
|
| Down Syndrome | 1 | 2017 | 47 | 0.500 |
Why?
|
| Monitoring, Ambulatory | 1 | 2017 | 56 | 0.490 |
Why?
|
| Patient Discharge | 7 | 2022 | 521 | 0.480 |
Why?
|
| Child, Preschool | 14 | 2025 | 2074 | 0.480 |
Why?
|
| Respiratory Function Tests | 3 | 2024 | 195 | 0.470 |
Why?
|
| Home Care Services | 3 | 2025 | 105 | 0.470 |
Why?
|
| Asthma | 2 | 2017 | 485 | 0.450 |
Why?
|
| Respiration | 2 | 2024 | 97 | 0.430 |
Why?
|
| Health Care Costs | 1 | 2017 | 224 | 0.430 |
Why?
|
| Child | 16 | 2024 | 4632 | 0.430 |
Why?
|
| Quality of Life | 2 | 2020 | 1264 | 0.430 |
Why?
|
| Hospitalization | 3 | 2023 | 1403 | 0.420 |
Why?
|
| Practice Guidelines as Topic | 3 | 2021 | 741 | 0.420 |
Why?
|
| Male | 28 | 2025 | 31281 | 0.410 |
Why?
|
| Female | 30 | 2025 | 34294 | 0.410 |
Why?
|
| Respiratory Aspiration | 1 | 2013 | 5 | 0.410 |
Why?
|
| Respiratory Mechanics | 2 | 2017 | 56 | 0.410 |
Why?
|
| Deglutition | 1 | 2013 | 20 | 0.400 |
Why?
|
| Eating | 1 | 2013 | 140 | 0.380 |
Why?
|
| Equipment Failure | 1 | 2013 | 69 | 0.380 |
Why?
|
| Posture | 1 | 2013 | 128 | 0.370 |
Why?
|
| Patient Readmission | 2 | 2017 | 452 | 0.360 |
Why?
|
| Professional Practice | 1 | 2011 | 24 | 0.350 |
Why?
|
| Social Determinants of Health | 2 | 2025 | 150 | 0.320 |
Why?
|
| Diuretics | 2 | 2025 | 58 | 0.320 |
Why?
|
| Infant Equipment | 1 | 2010 | 2 | 0.310 |
Why?
|
| Patient Safety | 1 | 2013 | 281 | 0.300 |
Why?
|
| Prospective Studies | 6 | 2025 | 3328 | 0.300 |
Why?
|
| Parents | 3 | 2024 | 416 | 0.300 |
Why?
|
| Emergency Service, Hospital | 2 | 2012 | 1163 | 0.290 |
Why?
|
| Boston | 4 | 2021 | 260 | 0.280 |
Why?
|
| Analgesics, Opioid | 2 | 2025 | 530 | 0.270 |
Why?
|
| Receptors, IgG | 1 | 2007 | 41 | 0.260 |
Why?
|
| Trachea | 3 | 2017 | 83 | 0.260 |
Why?
|
| Risk Factors | 7 | 2021 | 5466 | 0.260 |
Why?
|
| Pneumonia, Bacterial | 1 | 2007 | 91 | 0.250 |
Why?
|
| Logistic Models | 4 | 2015 | 1273 | 0.250 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2007 | 132 | 0.240 |
Why?
|
| Severity of Illness Index | 4 | 2025 | 1567 | 0.240 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2020 | 808 | 0.230 |
Why?
|
| Vibration | 1 | 2025 | 24 | 0.220 |
Why?
|
| Furosemide | 1 | 2025 | 19 | 0.220 |
Why?
|
| Touch | 1 | 2025 | 27 | 0.220 |
Why?
|
| Infant, Extremely Low Birth Weight | 2 | 2016 | 6 | 0.220 |
Why?
|
| Infant, Low Birth Weight | 3 | 2015 | 59 | 0.220 |
Why?
|
| Hypersensitivity | 1 | 2025 | 73 | 0.220 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2025 | 43 | 0.210 |
Why?
|
| United States | 10 | 2022 | 8165 | 0.210 |
Why?
|
| Air Pollution, Indoor | 1 | 2024 | 38 | 0.210 |
Why?
|
| Time Factors | 3 | 2025 | 3776 | 0.200 |
Why?
|
| Pediatrics | 3 | 2017 | 264 | 0.200 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 931 | 0.190 |
Why?
|
| Cannula | 1 | 2022 | 23 | 0.180 |
Why?
|
| Polysomnography | 2 | 2021 | 60 | 0.180 |
Why?
|
| Reference Values | 2 | 2013 | 328 | 0.170 |
Why?
|
| Respiratory Tract Diseases | 1 | 2021 | 40 | 0.170 |
Why?
|
| Child Health | 1 | 2022 | 33 | 0.170 |
Why?
|
| Chickenpox Vaccine | 1 | 2001 | 4 | 0.170 |
Why?
|
| Nutrition Policy | 1 | 2021 | 42 | 0.170 |
Why?
|
| Chickenpox | 1 | 2001 | 4 | 0.170 |
Why?
|
| Adolescent Development | 1 | 2021 | 18 | 0.170 |
Why?
|
| Licensure | 1 | 2001 | 14 | 0.170 |
Why?
|
| Surveys and Questionnaires | 5 | 2025 | 2788 | 0.170 |
Why?
|
| Lung | 2 | 2021 | 969 | 0.160 |
Why?
|
| Tracheomalacia | 2 | 2017 | 5 | 0.160 |
Why?
|
| Respiratory System Agents | 1 | 2020 | 6 | 0.160 |
Why?
|
| Child Development | 1 | 2021 | 87 | 0.160 |
Why?
|
| Multicenter Studies as Topic | 1 | 2020 | 160 | 0.150 |
Why?
|
| Qualitative Research | 1 | 2024 | 762 | 0.150 |
Why?
|
| Body Mass Index | 2 | 2021 | 900 | 0.150 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2019 | 27 | 0.150 |
Why?
|
| Respiration Disorders | 1 | 2019 | 26 | 0.140 |
Why?
|
| Drug Utilization | 1 | 2020 | 204 | 0.140 |
Why?
|
| Catheterization, Peripheral | 1 | 2019 | 51 | 0.140 |
Why?
|
| Infant, Extremely Premature | 1 | 2019 | 43 | 0.140 |
Why?
|
| Respiration, Artificial | 2 | 2023 | 300 | 0.140 |
Why?
|
| Cohort Studies | 2 | 2016 | 2639 | 0.140 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 2729 | 0.130 |
Why?
|
| Hypertension, Pulmonary | 2 | 2010 | 100 | 0.130 |
Why?
|
| Milk, Human | 1 | 2019 | 100 | 0.130 |
Why?
|
| Prevalence | 2 | 2025 | 1453 | 0.130 |
Why?
|
| Opioid-Related Disorders | 1 | 2025 | 531 | 0.130 |
Why?
|
| Citrates | 1 | 2017 | 19 | 0.130 |
Why?
|
| Mothers | 1 | 2021 | 281 | 0.130 |
Why?
|
| Outpatients | 3 | 2023 | 143 | 0.130 |
Why?
|
| Esophagoplasty | 1 | 2016 | 4 | 0.120 |
Why?
|
| Esophageal Atresia | 1 | 2016 | 9 | 0.120 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2016 | 5 | 0.120 |
Why?
|
| Infant Care | 1 | 2016 | 24 | 0.120 |
Why?
|
| New England | 2 | 2017 | 271 | 0.120 |
Why?
|
| Thoracotomy | 1 | 2016 | 47 | 0.120 |
Why?
|
| Cost Savings | 1 | 2017 | 60 | 0.120 |
Why?
|
| Anastomotic Leak | 1 | 2016 | 36 | 0.120 |
Why?
|
| Anastomosis, Surgical | 1 | 2016 | 118 | 0.120 |
Why?
|
| Hospital Costs | 1 | 2016 | 126 | 0.120 |
Why?
|
| Saliva | 1 | 2016 | 100 | 0.120 |
Why?
|
| Tracheobronchomalacia | 1 | 2015 | 1 | 0.110 |
Why?
|
| Bronchi | 1 | 2015 | 86 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 710 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2019 | 468 | 0.110 |
Why?
|
| Reproducibility of Results | 2 | 2023 | 1715 | 0.110 |
Why?
|
| Age Factors | 3 | 2021 | 1592 | 0.100 |
Why?
|
| Incidence | 2 | 2013 | 1432 | 0.100 |
Why?
|
| Sucking Behavior | 1 | 2013 | 1 | 0.100 |
Why?
|
| Barium | 1 | 2013 | 8 | 0.100 |
Why?
|
| Health Status | 1 | 2016 | 448 | 0.100 |
Why?
|
| Treatment Outcome | 4 | 2025 | 5818 | 0.100 |
Why?
|
| Inpatients | 1 | 2016 | 322 | 0.100 |
Why?
|
| Longitudinal Studies | 3 | 2025 | 1288 | 0.100 |
Why?
|
| Equipment Safety | 1 | 2013 | 29 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2016 | 888 | 0.100 |
Why?
|
| New York | 1 | 2013 | 144 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2013 | 182 | 0.090 |
Why?
|
| Morbidity | 2 | 2022 | 110 | 0.090 |
Why?
|
| Postoperative Complications | 2 | 2016 | 1335 | 0.090 |
Why?
|
| Needs Assessment | 1 | 2013 | 202 | 0.090 |
Why?
|
| Tachykinins | 1 | 2011 | 8 | 0.090 |
Why?
|
| Complement C3a | 1 | 2011 | 7 | 0.090 |
Why?
|
| Vital Signs | 1 | 2011 | 11 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2013 | 755 | 0.090 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2011 | 26 | 0.090 |
Why?
|
| Equipment Design | 1 | 2013 | 373 | 0.090 |
Why?
|
| Pulmonary Medicine | 1 | 2011 | 41 | 0.080 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2011 | 39 | 0.080 |
Why?
|
| Ambulatory Care Facilities | 1 | 2011 | 104 | 0.080 |
Why?
|
| Interleukin-17 | 1 | 2011 | 101 | 0.080 |
Why?
|
| Tracheotomy | 1 | 2010 | 7 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2013 | 310 | 0.080 |
Why?
|
| Contraindications | 1 | 2010 | 52 | 0.080 |
Why?
|
| Tracheostomy | 2 | 2023 | 36 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 1116 | 0.080 |
Why?
|
| Referral and Consultation | 2 | 2024 | 445 | 0.070 |
Why?
|
| Lung Diseases | 1 | 2010 | 183 | 0.070 |
Why?
|
| Adolescent | 4 | 2021 | 6348 | 0.070 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2007 | 1 | 0.070 |
Why?
|
| Complement C5a | 1 | 2007 | 5 | 0.070 |
Why?
|
| Capillary Permeability | 1 | 2007 | 17 | 0.070 |
Why?
|
| Phagocytes | 1 | 2007 | 52 | 0.070 |
Why?
|
| Cytokines | 2 | 2011 | 964 | 0.070 |
Why?
|
| Adult | 4 | 2024 | 17507 | 0.060 |
Why?
|
| Pseudomonas Infections | 1 | 2007 | 73 | 0.060 |
Why?
|
| Leukocytes | 1 | 2007 | 110 | 0.060 |
Why?
|
| Antibodies, Bacterial | 1 | 2007 | 181 | 0.060 |
Why?
|
| Massachusetts | 2 | 2024 | 2154 | 0.060 |
Why?
|
| Phagocytosis | 1 | 2007 | 257 | 0.060 |
Why?
|
| Babesiosis | 1 | 2006 | 13 | 0.060 |
Why?
|
| Transfusion Reaction | 1 | 2006 | 46 | 0.060 |
Why?
|
| Hospital Mortality | 1 | 2010 | 879 | 0.060 |
Why?
|
| Cell Movement | 1 | 2007 | 482 | 0.060 |
Why?
|
| Survival Rate | 1 | 2007 | 847 | 0.060 |
Why?
|
| Stochastic Processes | 1 | 2025 | 28 | 0.060 |
Why?
|
| Partial Pressure | 1 | 2024 | 9 | 0.050 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2024 | 55 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2024 | 111 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2021 | 744 | 0.050 |
Why?
|
| Communication Barriers | 1 | 2024 | 71 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2025 | 745 | 0.050 |
Why?
|
| Child Health Services | 1 | 2024 | 68 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2025 | 858 | 0.050 |
Why?
|
| Ventilators, Mechanical | 1 | 2023 | 28 | 0.050 |
Why?
|
| Child Day Care Centers | 1 | 2022 | 11 | 0.050 |
Why?
|
| Steroids | 1 | 2022 | 56 | 0.050 |
Why?
|
| Interviews as Topic | 1 | 2024 | 535 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2022 | 98 | 0.040 |
Why?
|
| Aftercare | 1 | 2021 | 77 | 0.040 |
Why?
|
| Phenotype | 1 | 2025 | 1235 | 0.040 |
Why?
|
| Cellulitis | 1 | 2001 | 16 | 0.040 |
Why?
|
| Echocardiography | 1 | 2024 | 513 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2021 | 123 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2001 | 56 | 0.040 |
Why?
|
| Consensus | 1 | 2021 | 177 | 0.040 |
Why?
|
| Inflammation | 1 | 2007 | 1195 | 0.040 |
Why?
|
| Forced Expiratory Volume | 1 | 2021 | 213 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2001 | 104 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 3500 | 0.040 |
Why?
|
| Societies | 1 | 2019 | 24 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 603 | 0.040 |
Why?
|
| Vaccination | 1 | 2001 | 388 | 0.030 |
Why?
|
| Mice | 2 | 2011 | 11172 | 0.030 |
Why?
|
| Registries | 1 | 2021 | 933 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 691 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 296 | 0.030 |
Why?
|
| Esophageal Stenosis | 1 | 2016 | 5 | 0.030 |
Why?
|
| Diverticulum | 1 | 2016 | 12 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2017 | 88 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2016 | 130 | 0.030 |
Why?
|
| Algorithms | 1 | 2021 | 1051 | 0.030 |
Why?
|
| Animals | 3 | 2011 | 21450 | 0.030 |
Why?
|
| Reoperation | 1 | 2016 | 307 | 0.030 |
Why?
|
| Mass Screening | 1 | 2020 | 700 | 0.030 |
Why?
|
| Recurrence | 1 | 2016 | 664 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1144 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2113 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2016 | 337 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 2392 | 0.020 |
Why?
|
| Pneumonia | 1 | 2015 | 295 | 0.020 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2011 | 18 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 2496 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 147 | 0.020 |
Why?
|
| Models, Biological | 1 | 2016 | 1193 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 4855 | 0.020 |
Why?
|
| Respiratory System Abnormalities | 1 | 2010 | 3 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 449 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 542 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 70 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2011 | 664 | 0.020 |
Why?
|
| Age Distribution | 1 | 2010 | 262 | 0.020 |
Why?
|
| Risk | 1 | 2010 | 374 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2010 | 96 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2010 | 101 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2010 | 252 | 0.020 |
Why?
|
| Gene Expression | 1 | 2011 | 854 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 797 | 0.020 |
Why?
|
| Surface-Active Agents | 1 | 2007 | 116 | 0.020 |
Why?
|
| Middle Aged | 1 | 2024 | 18431 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2011 | 2168 | 0.010 |
Why?
|
| Babesia | 1 | 2006 | 2 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 1791 | 0.010 |
Why?
|